| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,349 | 2,945 | 3,150 | 5,480 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 6,349 | 2,945 | 3,150 | 5,480 | | | Operating Expenses | | Research Development | 7,472 | 5,804 | 4,495 | 5,430 | | Selling General and Administrative | 1,800 | 2,206 | 2,220 | 2,944 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,923) | (5,065) | (3,565) | (2,894) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,181) | (14,588) | 2,638 | 1,753 | | Earnings Before Interest And Taxes | (8,104) | (19,653) | (927) | (1,141) | | Interest Expense | (15) | 15 |
-
|
-
| | Income Before Tax | (8,089) | (19,668) | (927) | (1,141) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,089) | (19,668) | (927) | (1,141) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,089) | (19,668) | (927) | (1,141) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,089) | ($19,668) | ($927) | ($1,141) |
|
0.44% Nasdaq 
Income Statement
